Technology | June 16, 2009

MILabs Wins Two Contracts for Low-Dose SPECT/CT

U-SPECT/CT

June 16, 2009 – MILabs introduced at the Annual SNM meeting its novel U-SPECT/CT system, a Micro-SPECT system that is fully integrated with the MILabs high-throughput, low dose U-CT. The company also announced it has already contracted to install two U-SPECT/CT systems.

Delft University of Technology will upgrade their U-SPECT-II system to a U-SPECT/CT this summer. The University Medical Centre St. Radboud in Nijmegen, The Netherlands, has ordered to expand their small animal imaging facilities with U-SPECT/CT. The system will be used to perform research on new radiopharmaceuticals for both diagnostic and therapeutic applications. For this research objective extremely low-dose studies will be performed with U-SPECT/CT.

Professor Otto Boerman, University Medical Centre St. Radboud said, "The new system provides very detailed molecular images, that will allow us to monitor fast tracer dynamics in sub-compartments of the tiny organs or tumors in a mouse or rat but also shows detailed tracer dynamics in the entire body."

According to MILabs, the integrated CT makes it possible to look at a wide range of isotopes and combinations of isotopes at the sub-half-mm resolution level and localize the tracers with the same accuracy in the anatomical framework provided by the fully integrated X-ray CT.

For more information: www.milabs.com

Related Content

Cardiac MRI being performed at the DeBakey Heart Hospital.

Cardiac MRI being performed at the DeBakey Heart Hospital.

Feature | Cardiac Imaging | May 03, 2018 | By Jeff Zagoudis
Magnetic resonance imaging (MRI) for cardiac assessment provides a radiation-free alternative to other commonly used...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
GE Healthcare SPECT/CT and PET/CT Systems Enhance Personalized Patient Care
News | Nuclear Imaging | June 10, 2017
GE Healthcare showcased positron emission tomography (PET) and single photon emission computed tomography/computed...
advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...
News | SPECT-CT | June 08, 2017
Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine &...
Videos | Nuclear Imaging | April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
xSPECT Quant technology, SPECT/CT, Symbia Intevo, Siemens Healthineers, RSNA 2016
News | SPECT Imaging | December 06, 2016
December 6, 2016 — At the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (
Siemens Healthineers, Symbia Intevo SPECT/CT system, xSPECT Quant, RSNA 2016
Technology | SPECT-CT | October 18, 2016
October 18, 2016 — At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Siemens Healt
Overlay Init